A diagnostic challenge in an individual with Paracoccidioidomycosis during hospitalization in times of COVID-19

Authors

DOI:

https://doi.org/10.31686/ijier.vol10.iss2.3660

Keywords:

Fungal Infection, Paracoccidioidomycosis, Oral Diagnosis

Abstract

Paracoccidioidomycosis (PCM) is a deep fungal infection, endemic with considerable morbidity in South America, whose first symptoms can occur in the oral cavity. A 47-year-old male patient, leucoderma, living on the streets, presenting dyspnea, pain during the speech, and dysphagia, was referred for admission to the ICU for suspected COVID-19 infection. The intensive care physician's evaluation revealed a tongue lesion with suspected carcinoma. By dentist investigation, was observed the presence of moriform lesions with high borders delimitation in the tongue. Also, granulomatous ulcers with irregular texture, suggesting moriform stomatitis, the chest tomography revealed diffuse thickening of the bronchial walls, indicating chronic bronchopathy with discrete centrilobular nodules, sometimes confluent. Incisional tongue biopsy associated with lung imaging confirmed the diagnosis of PCM, and the patient was referred to the referral center for the treatment of fungal diseases. The involvement of the oral environment as a region to the appearance of detectable first symptoms of PCM suggests the need for the oral evaluation by a specialist as a diagnostic tool.

Downloads

Download data is not yet available.

Author Biographies

  • Mario E. Baldo, Federal University of Mato Grosso do Sul

    PhD degree student - Postgraduate Program in Health and Development in the Midwest Region

  • Regina Maria Raffaele, MS Santa Casa Hospital

    Dental Surgeon, Qualified in Hospital Dental Care; Head of the ICU Dentistry Service at Associação Beneficente de Campo Grande- MS Santa Casa Hospital.

  • Paulo Sérgio da Silva Santos, Bauru School of Dentistry

    Dental Surgeon, Associate Professor at the Department of Surgery, Stomatology, Pathology and Radiology at the Bauru School of Dentistry – University of São Paulo.

  • Rondon Tosta Ramalho, Federal University of Mato Grosso do Sul

    Full Professor, Postgraduate Program in Health and Development in the Midwest Region, UFMS, Campo Grande-MS, Brazil.

  • Luiz Carlos Takita, Federal University of Mato Grosso do Sul

    Assistant Professor pathology – FAMED / UFMS

References

Tarantino A.B, Gonçalves A.JR, Capone D, Aide M.A, Lazera M.S, Wanke B. Micoses Pulmonares. In: Tarantino AB, editor. Doenças Pulmonares. Rio de Janeiro: Guanabara Koogan; 2002: 416-50.

Moreira, A. P. V. . Paracoccidioidomicose: histórico, etiologia, epidemiologia, patogênese, formas clínicas, diagnóstico laboratorial e antígenos. BEPA. Boletim Epidemiológico Paulista (Online). 2008; 5(51): 11-24.

Shikanai-Yasuda, M. A., Mendes, R. P., Colombo, A. L., Queiroz-Telles, F. D., Kono, A. S. G., Paniago, A. M., ... & Martinez, R. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Revista da Sociedade Brasileira de Medicina Tropical. 2017; 50: 715-740. DOI: https://doi.org/10.1590/0037-8682-0230-2017

Trindade, A. H., Meira, H. C., Pereira, I. F., de Lacerda, J. C. T., de Mesquita, R. A., & Santos, V. R. Oral paracoccidioidomycosis: retrospectiveanalysisof 55 Brazilianpatients. Mycoses. 2017; 60(8): 521-525. DOI: https://doi.org/10.1111/myc.12622

Brazão‐Silva, M. T., Andrade, M. F., Franco, T., Ribeiro, R. I. M. A., Silva, W. D. S., Faria, G., ... & Loyola, A. M. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2011; 54(4): 189-195. DOI: https://doi.org/10.1111/j.1439-0507.2010.01873.x

GOMES, Elenice; WINGETER, Márcia Arias; SVIDZINSKI, Terezinha Inez Estivalet. Clinical-radiologicaldissociation in lungmanifestationsofparacoccidioidomycosis. Revista da Sociedade Brasileira de Medicina Tropical, v. 41, n. 5, 2008. p. 454-458. DOI: https://doi.org/10.1590/S0037-86822008000500004

Vicente, C. R., &Falqueto, A. (2018). Differentiation of mucosal lesions in mucocutaneousleishmaniasis and paracoccidioidomycosis. PLoSOne, 13(11), e0208208. DOI: https://doi.org/10.1371/journal.pone.0208208

Sanches LC, Faria MCI. A importância do diagnóstico diferencial entre a paracoccidioidomicose (PCM) e tuberculose (TB). RevUnigáReview 2014;20(1):76-80.

Costa, M. D. C., de Carvalho, M. M., Sperandio, F. F., Ribeiro Junior, N. V., Hanemann, J. A. C., Pigossi, S. C., & de Carli, M. L. Oral Paracoccidioidomycosis affecting women: A systematic review. Mycoses, 2021; 64(2): 108-122. DOI: https://doi.org/10.1111/myc.13194

Martinez, R. New trends in paracoccidioidomycosis epidemiology. Journaloffungi, 2017; 3(1): 1. DOI: https://doi.org/10.3390/jof3010001

Costa, M. D. C., de Carvalho, M. M., Sperandio, F. F., Ribeiro Junior, N. V., Hanemann, J. A. C., Pigossi, S. C., & de Carli, M. L. Oral Paracoccidioidomycosis affecting women: A systematic review. Mycoses. 2021; 64(2): 108-122. DOI: https://doi.org/10.1111/myc.13194

Iranmanesh, B., Khalili, M., Amiri, R., Zartab, H., &Aflatoonian, M. Oral manifestations of COVID‐19 disease: A review article. Dermatologic therapy.2021; 34(1): e14578. DOI: https://doi.org/10.1111/dth.14578

Surboyo, M. D., Ernawati, D. S., & Budi, H. S. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection. Minerva Dental and Oral Science.2021;161-168. DOI: https://doi.org/10.23736/S2724-6329.21.04493-9

Paradowska-Stolarz, A. M. . Oral manifestations of COVID-19: Brief review. Dental and Medical Problems.2021; 58(1): 123-126. DOI: https://doi.org/10.17219/dmp/131989

de Souza Gomide, M. R. F., Cintra, L. T. A., Durlacher, R. R., Benetti, F., &Guimarães, G. Oral biopsy for early diagnosis of paracoccidioidomycosis. Mycopathologia. 2019; 184(1): 193-194. DOI: https://doi.org/10.1007/s11046-018-0311-4

de Paulo, L. F. B., de Faria, L. S., & Durighetto, A. F. Endemic oral paracoccidioidomycosis: clinical presentation, management, and outcomes. International Journal of Infectious Diseases.2014; 19: 109-110. DOI: https://doi.org/10.1016/j.ijid.2013.09.018

de Arruda, J. A. A., Schuch, L. F., Abreu, L. G., Silva, L. V. D. O., Mosconi, C., Monteiro, J. L. G. C., ... &Mesquita, R. A. A multicentre study of oral paracoccidioidomycosis: Analysis of 320 cases and literature review. Oral diseases. 2018; 24(8): 1492-1502. DOI: https://doi.org/10.1111/odi.12925

Azenha, M. R., Caliento, R., Brentegani, L. G., & Lacerda, S. A. D. A retrospective study of oral manifestations in patients with paracoccidioidomycosis. Brazilian Dental Journal.2012; 23: 753-757. DOI: https://doi.org/10.1590/S0103-64402012000600021

Travassos, L. R., Taborda, C. P., & Colombo, A. L. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert review of anti-infective therapy. 2008; 6(2):251-262. DOI: https://doi.org/10.1586/14787210.6.2.251

Benard, G. An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia. 2008; 165(4): 209-221. DOI: https://doi.org/10.1007/s11046-007-9065-0

Cordova, L. A., & Torres, J. Paracoccidioidomycosis. StatPearls 2021 [Internet] PMID: 33085335

Shikanai-Yasuda, M. A., Mendes, R. P., Colombo, A. L., Telles, F. D. Q., Kono, A., Paniago, A. M. M., ... & Martinez, R. II consenso brasileiro em paracoccidioidomicose. Epidemiologia e Serviços de Saúde. 2018; 27: e0500001. DOI: https://doi.org/10.5123/S1679-49742018000500001

Andrade, U. V., Oliveira, S. M. D. V. L. D., Chang, M. R., Pereira, E. F., Marques, A. P. D. C., Carvalho, L. R. D., ... &Paniago, A. M. M. (2019). Adesão ao tratamento de pacientes com paracoccidioidomicose na Região Centro-Oeste do Brasil. Jornal Brasileiro de Pneumologia, 45.

Martinez, R. New trends in paracoccidioidomycosisepidemiology. Journal of fungi. 2017; 3(1): 1. DOI: https://doi.org/10.3390/jof3010001

Paniago, A. M., & Martinez, R. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Revista da Sociedade Brasileira de Medicina Tropical. 2017; 50: 715-740. DOI: https://doi.org/10.1590/0037-8682-0383-2017

Del Fiol, F. S., Oliveira, S. D. J., Barberato-Filho, S., Junqueira, F. M., Rocha, M. C. P. D., & Toledo, M. I. D. Paracoccidioidomycosis: evaluation of treatment and patient profile. Brazilian Journal of Infectious Diseases. 2013; 17: 720-721. DOI: https://doi.org/10.1016/j.bjid.2013.07.001

Nery, A. F., Crepaldi, N. P., Rossi, S. B., Tadano, T., Leal-Santos, F. A., Hahn, R. C., & Fontes, C. J. F. Therapeutic response in adult patients with nonsevere chronic paracoccidioidomycosis treated with sulfamethoxazole–trimethoprim: a retrospective study. The American journal of tropical medicine and hygiene. 2017: 97(2): 556. DOI: https://doi.org/10.4269/ajtmh.16-0255

Tomo, S., da Silva, R. L., Miyahara, G. I., Stefanini, A. R., & Simonato, L. E. Diagnosis and treatment of primary paracoccidioidomycosis in oral mucosa. Dermatologic therapy. 2020; 33(3): e13314. DOI: https://doi.org/10.1111/dth.13314

do Valle, A. C. F., de Macedo, P. M., Almeida-Paes, R., Romão, A. R., dos Santos Lazéra, M., &Wanke, B. Paracoccidioidomycosis after highway construction, Rio de Janeiro, Brazil. Emerging infectious diseases. 2017; 23(11): 1917. DOI: https://doi.org/10.3201/eid2311.170934

Downloads

Published

2022-02-01

How to Cite

Baldo, M. E., Raffaele, R. M. ., da Silva Santos, P. S. ., Ramalho, R. T., & Takita, L. C. . (2022). A diagnostic challenge in an individual with Paracoccidioidomycosis during hospitalization in times of COVID-19. International Journal for Innovation Education and Research, 10(2), 149-158. https://doi.org/10.31686/ijier.vol10.iss2.3660
Received 2022-01-16
Accepted 2022-01-27
Published 2022-02-01

Most read articles by the same author(s)